Factors associated with mortality among heroin users after seeking treatment with methadone: A population-based cohort study in Taiwan

Journal of Substance Abuse Treatment

Volumn 44, Issue 3, 2013, Pages 295-300

  Huang, Charles Lung Cheng ^a,b   Lee, Chung Wei ^c  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cohort study; Han Chinese; Heroin dependence; Methadone; Mortality

Indexed keywords

DIAMORPHINE; METHADONE;

ACCIDENT; ADULT; ALCOHOL ABUSE; ALCOHOLISM; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DRUG OVERDOSE; FEMALE; HEROIN DEPENDENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER DISEASE; MALE; METHADONE TREATMENT; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHIATRIC TREATMENT; SUICIDE; TAIWAN;

ACCIDENTS; ADULT; AGE FACTORS; COHORT STUDIES; DRUG OVERDOSE; HEROIN DEPENDENCE; HUMANS; METHADONE; OPIATE SUBSTITUTION TREATMENT; PATIENT ACCEPTANCE OF HEALTH CARE; RISK FACTORS; TAIWAN;

EID: 84872273574     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2012.08.003     Document Type: Article

References (58)

1. Adelekan M., Green A., Dasgupta N., Tallack F., Stimson G.V., Wells B. Reliability and validity of the Opiate Treatment Index among a sample of opioid users in the United Kingdom. Drug and Alcohol Review 1996, 15:261-270.
2. Amato L., Davoli M., Perucci C.A., Ferri M., Faggiano F., Mattick R.P. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research. Journal of Substance Abuse Treatment 2005, 28:321-329.
3. Bargagli A.M., Hickman M., Davoli M., Perucci C.A., Schifano P., Buster M. Drug-related mortality and its impact on adult mortality in eight European countries. European Journal of Public Health 2006, 16:198-202.
4. Bauer S.M., Loipl R., Jagsch R., Gruber D., Risser D., Thau K. Mortality in opioid-maintained patients after release from an addiction clinic. European Addiction Research 2008, 14:82-91.
5. Bradvik L., Berglund M., Frank A., Lindgren A., Lowenhielm P. Number of addictive substances used related to increased risk of unnatural death: A combined medico-legal and case-record study. BMC Psychiatry 2009, 9:48.
6. Brugal M.T., Domingo-Salvany A., Puig R., Barrio G., Garcia de Olalla P., de la Fuente L. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction 2005, 100:981-989.
7. Buster M.C., van Brussel G.H., van den Brink W. An increase in overdose mortality during the first 2 weeks after entering or re-entering methadone treatment in Amsterdam. Addiction 2002, 97:993-1001.
8. Cairns A., Roberts I.S., Benbow E.W. Characteristics of fatal methadone overdose in Manchester, 1985-94. BMJ 1996, 313:264-265.
9. Caplehorn J.R., Dalton M.S., Cluff M.C., Petrenas A.M. Retention in methadone maintenance and heroin addicts' risk of death. Addiction 1994, 89:203-209.
10. Centers for Disease Control Methadone maintenance treatment guidelines 2007, Department of Health. (Taipei: Taiwan).
11. Chen I.C., Chie W.C., Hwu H.G., Chou S.Y., Yeh Y.C., Yu C.Y. Alcohol use problem among patients in methadone maintenance treatment in Taiwan. Journal of Substance Abuse Treatment 2011, 40:142-149.
12. Chen V.C., Lin T.Y., Lee C.T., Lai T.J., Chen H., Ferri C.P. Suicide attempts prior to starting methadone maintenance treatment in Taiwan. Drug and Alcohol Dependence 2010, 109:139-143.
13. Chiang S.C., Chan H.Y., Chang Y.Y., Sun H.J., Chen W.J., Chen C.K. Psychiatric comorbidity and gender difference among treatment-seeking heroin abusers in Taiwan. Psychiatry and Clinical Neurosciences 2007, 61:105-111.
14. Chugh S.S., Socoteanu C., Reinier K., Waltz J., Jui J., Gunson K. A community-based evaluation of sudden death associated with therapeutic levels of methadone. American Journal of Medicine 2008, 121:66-71.
15. Cornish R., Macleod J., Strang J., Vickerman P., Hickman M. Risk of death during and after opiate substitution treatment in primary care: Prospective observational study in UK General Practice Research Database. BMJ 2011, 341:c5475.
16. Cousins G., Teljeur C., Motterlini N., McCowan C., Dimitrov B.D., Fahey T. Risk of drug-related mortality during periods of transition in methadone maintenance treatment: A cohort study. Journal of Substance Abuse Treatment 2011, 41:252-260.
17. Mortality amongst illicit drug users 2006, Cambridge University Press, Cambridge. S. Darke, L. Degenhardt, R.P. Mattick (Eds.).
18. Darke S., Hall W., Wodak A., Heather N., Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: pp 2-27. The Opiate Treatment Index. British Journal of Addiction 1992, 87:733-742.
19. Darke S., Kaye S., Duflou J. Systemic disease among cases of fatal opioid toxicity. Addiction 2006, 101:1299-1305.
20. Davoli M., Perucci C.A., Forastiere F., Doyle P., Rapiti E., Zaccarelli M. Risk factors for overdose mortality: A case-control study within a cohort of intravenous drug users. International Journal of Epidemiology 1993, 22:273-277.
21. Deering D.E., Sellman J.D. An inter-rater reliability study of the Opiate Treatment Index. Drug and Alcohol Review 1996, 15:57-63.
22. Degenhardt L., Bucello C., Mathers B., Briegleb C., Ali H., Hickman M. Mortality among regular or dependent users of heroin and other opioids: A systematic review and meta-analysis of cohort studies. Addiction 2011, 106:32-51.
23. Degenhardt L., Hall W., Lynskey M., Warner-Smith M. Illicit drug use. Comparative quantification of health risks: Global and regional burden of disease attributable to selected major risk factors 2004, 2:1109-1176. World Health Organization, Geneva. M. Ezzati, A.D. Lopez, A. Rodgers, R. Murray (Eds.).
24. Degenhardt L., Randall D., Hall W., Law M., Butler T., Burns L. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: Risk factors and lives saved. Drug and Alcohol Dependence 2009, 105:9-15.
25. Department of Health Regulations for the management of opioid dependence 2006, Executive Yuan. (Taipei: Taiwan).
26. Department of Health Health statistics in Taiwan 2007, Executive Yuan. (Taipei: Taiwan).
27. Department of Health Health statistics in Taiwan 2008, Executive Yuan. (Taipei: Taiwan).
28. Drummer O.H., Opeskin K., Syrjanen M., Cordner S.M. Methadone toxicity causing death in ten subjects starting on a methadone maintenance program. American Journal of Forensic Medicine and Pathology 1992, 13:346-350.
29. Esteban J., Gimeno C., Barril J., Aragones A., Climent J.M., de la Cruz Pellin M. Survival study of opioid addicts in relation to its adherence to methadone maintenance treatment. Drug and Alcohol Dependence 2003, 70:193-200.
30. Ghodse A.H., Sheehan M., Taylor C., Edwards G. Deaths of drug addicts in the United Kingdom 1967-81. British Medical Journal (Clinical Research Ed.) 1985, 290:425-428.
31. Gibson A., Degenhardt L., Mattick R.P., Ali R., White J., O'Brien S. Exposure to opioid maintenance treatment reduces long-term mortality. Addiction 2008, 103:462-468.
32. Gossop M., Stewart D., Treacy S., Marsden J. A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction 2002, 97:39-47.
33. Gronbladh L., Ohlund L.S., Gunne L.M. Mortality in heroin addiction: Impact of methadone treatment. Acta Psychiatrica Scandinavica 1990, 82:223-227.
34. Hall W., Lynskey M., Degenhardt L. Trends in opiate-related deaths in the United Kingdom and Australia, 1985-1995. Drug and Alcohol Dependence 2000, 57:247-254.
35. Harding-Pink D. Methadone: One person's maintenance dose is another's poison. Lancet 1993, 341:665-666.
36. Hser Y.I., Hoffman V., Grella C.E., Anglin M.D. A 33-year follow-up of narcotics addicts. Archives of General Psychiatry 2001, 58:503-508.
37. Huang Y.F., Kuo H.S., Lew-Ting C.Y., Tian F., Yang C.H., Tsai T.I. Mortality among a cohort of drug users after their release from prison: An evaluation of the effectiveness of a harm reduction program in Taiwan. Addiction 2011, 106:1437-1445.
38. Hulse G.K., English D.R., Milne E., Holman C.D. The quantification of mortality resulting from the regular use of illicit opiates. Addiction 1999, 94:221-229.
39. Jimenez-Trevino L., Saiz P.A., Garcia-Portilla M.P., Diaz-Mesa E.M., Sanchez-Lasheras F., Buron P. A 25-year follow-up of patients admitted to methadone treatment for the first time: Mortality and gender differences. Addictive Behaviors 2011, 36:1184-1190.
40. Kleber H.D. Methadone maintenance 4 decades later: Thousands of lives saved but still controversial. Journal of the American Medical Association 2008, 300:2303-2305.
41. Lee H.Y., Li J.H., Wu L.T., Wu J.S., Yen C.F., Tang H.P. Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan. Substance Abuse Treatment, Prevention, and Policy 2012, 7:11.
42. Lee T.S., Shen H.C., Wu W.H., Huang C.W., Yen M.Y., Wang B.E. Clinical characteristics and risk behavior as a function of HIV status among heroin users enrolled in methadone treatment in northern Taiwan. Substance Abuse Treatment, Prevention, and Policy 2011, 6. [Epub ahead of print].
43. Mattick R.P., Breen C., Kimber J., Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews 2009, 1:CD002209.
44. McCowan C., Kidd B., Fahey T. Factors associated with mortality in Scottish patients receiving methadone in primary care: Retrospective cohort study. BMJ 2009, 338:b2225.
45. Morgan O., Griffiths C., Hickman M. Association between availability of heroin and methadone and fatal poisoning in England and Wales 1993-2004. International Journal of Epidemiology 2006, 35:1579-1585.
46. Muga R., Roca J., Egea J.M., Tor J., Sirera G., Rey-Joly C. Mortality of HIV-positive and HIV-negative heroin abusers as a function of duration of injecting drug use. Journal of Acquired Immune Deficiency Syndromes 2000, 23:332-338.
47. NIH Consensus Statement Effective medical treatment of opiate addiction 1997, National Institutes of Health, USA.
48. Oppenheimer E., Tobutt C., Taylor C., Andrew T. Death and survival in a cohort of heroin addicts from London clinics: A 22-year follow-up study. Addiction 1994, 89:1299-1308.
49. Patrick D.M., Tyndall M.W., Cornelisse P.G., Li K., Sherlock C.H., Rekart M.L. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. CMAJ 2001, 165:889-895.
50. Peles E., Schreiber S., Adelson M. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel. Drug and Alcohol Dependence 2010, 107:141-148.
51. Ravndal E., Vaglum P. Psychopathology, treatment completion and 5 years outcome. A prospective study of drug abusers. Journal of Substance Abuse Treatment 1998, 15:135-142.
52. Soyka M., Apelt S.M., Lieb M., Wittchen H.U. One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy: A nationally representative cohort study in 2694 patients. Journal of Clinical Psychopharmacology 2006, 26:657-660.
53. Srivastava A., Kahan M. Methadone induction doses: Are our current practices safe?. Journal of Addictive Diseases 2006, 25:5-13.
54. Tait R.J., Ngo H.T., Hulse G.K. Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment. Journal of Substance Abuse Treatment 2008, 35:116-124.
55. Tyndall M.W., Craib K.J., Currie S., Li K., O'Shaughnessy M.V., Schechter M.T. Impact of HIV infection on mortality in a cohort of injection drug users. Journal of Acquired Immune Deficiency Syndromes 2001, 28:351-357.
56. Ward J., Mattick R.P., Hall W., Darke S. The effectiveness and safety of methadone maintenance. Addiction 1996, 91:1727-1729.
57. Zador D. Methadone maintenance: Making it better. Addiction 2007, 102:350-351.
58. Zanis D.A., Woody G.E. One-year mortality rates following methadone treatment discharge. Drug and Alcohol Dependence 1998, 52:257-260.